Closing the HPV Testing Gap Act

The Closing the HPV Testing Gap Act directs the National Institutes of Health to conduct a comprehensive study on developing a standardized, noninvasive test for human papillomavirus in men. This research must be completed within 24 months and will involve coordination with federal agencies like the CDC and the FDA, as well as scientific experts and community stakeholders. The study aims to evaluate various testing methods, assess feasibility across diverse populations, and provide recommendations for future implementation and regulatory approval. Additionally, the bill requires an interagency working group to oversee the process and mandates a final report to Congress within 30 months outlining findings and strategies for improving cancer prevention and health equity.